Trials / Completed
CompletedNCT00000333
Evaluation of Benztropine for Cocaine Craving - 2
Evaluation of Efficacy of Benztropine for Cocaine Craving
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (planned)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- All
- Age
- 22 Years – 48 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the efficacy of benztropine (or DA reuptake inhibitor) with atropine and placebo in affecting stimulated craving to cocaine cues.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Benztropine |
Timeline
- Start date
- 2001-05-01
- Primary completion
- 2003-01-01
- Completion
- 2003-04-01
- First posted
- 1999-09-21
- Last updated
- 2017-02-24
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT00000333. Inclusion in this directory is not an endorsement.